Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Low-lead calcium marketing by two U.S. suppliers coincides with growing public concern.

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

PLUESS-STAUFER PLANS SECOND QUARTER AVAILABILITY OF LOW-LEAD CALCIUM for food and drug products after opening a new calcium carbonate quarry in California on Jan. 6. The privately held Lucerne Valley, Calif.-based company, whose parent corporation is based in Switzerland, claims to be the largest calcium carbonate supplier in the world. Availability of the low-lead calcium coincides with the growing public concern over lead levels in calcium supplements and OTC antacid products.

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

EU & South Korea Sign Deal On Exchange Of Confidential Information

Recent And Upcoming FDA Advisory Committee Meetings

Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity

Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy

See All
UsernamePublicRestriction

Register

PS086733

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By